A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis [DVT] of the upper extremity

Trial Profile

A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis [DVT] of the upper extremity

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2006

At a glance

  • Drugs Dalteparin sodium (Primary)
  • Indications Deep vein thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top